Century Pharmacy, Inc. Agrees to $100,000 Settlement Regarding Controlled Substances Act Claims | USAO-WDKY

Louisville, KY – Century Pharmacy, Inc., doing business as Century Medicines of Elizabethtown, has agreed to pay $100,000 to resolve allegations that it failed to meet the Act’s record-keeping requirements on controlled substances (CSA).

Century Medicines of Elizabethtown, KY, which is no longer in operation, has been registered with the Drug Enforcement Administration (DEA) as a retail pharmacy. It has been authorized to distribute controlled substances in accordance with the provisions of the CSA. The CSA requires that every registered pharmacy keep complete and accurate records of every controlled substance it receives and dispenses or releases. These requirements help ensure that controlled substances are properly managed, accounted for and available for legitimate needs, and not diverted for illegal purposes. Failure to keep proper records subjects DEA registrants to monetary civil penalties.

According to the settlement agreement, between 2016 and 2020, Century Medicines could not account for the distribution or disposal of approximately 85,000 hydrocodone and oxycodone tablets it purchased and received. Century Medicines reported to the DEA a suspected discrepancy between the pills received and distributed or disposed of, and cooperated with the investigation. He did not admit liability, but agreed to pay $100,000 to settle all claims related to the alleged conduct.

“This investigation and settlement agreement confirms our commitment to enforcing the CSA,” said Michael A. Bennett, U.S. Attorney for the Western District of Kentucky. “In partnership with the DEA, we will continue to aggressively investigate and prosecute violations of the law throughout the Western District.”

“Poor record keeping can contribute to the diversion of pharmaceuticals, and the DEA takes these issues very seriously,” said Special Agent in Charge J. Todd Scott of the DEA’s Louisville Division. “DEA registrants are required to comply with the Controlled Substances Act or face severe penalties, as evidenced by this case.”

The resolutions achieved in this case are the result of a coordinated effort between the US Attorney’s Office for the Western District of Kentucky and the Drug Enforcement Administration.

This matter was investigated by the DEA Louisville Division Diversion Program under the direction of Special Agent in Charge J. Todd Scott, the Kentucky State Police and the Kentucky Cabinet for Health and Family Services, Office of Inspector General.

Assistant District Attorney for the Western Kentucky District, Timothy D. Thompson, helped oversee the investigation and represented the United States in the settlement agreement.

The claims resolved by the settlement are allegations only and no liability has been determined.


Comments are closed.